Biology class just got a lot more engaging for students at Arizona State University Polytechnic, where students are using ...

Aditum’s newly formed biotech, dubbed Kalexo Bio, will develop the asset for patients with elevated cholesterol, or dyslipidemia, and for the prevention of high-risk atherosclerotic cardiovascular ...

Preclinical Data for OPK-8801003 Demonstrate Substantially Longer Biological Half-Life with Peak Plasma Levels Comparable to ...

This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply.

New Delhi [India], September 16: The Saudi Ministry of Health has announced the launch of the first edition of BIO Middle ...

No Option for Additional Subjects, Career Concerns Rise The Central Board of Secondary Education (CBSE) has introduced a ...

Check the latest CBSE Class 10 Exam Pattern 2025-26 with revised question paper pattern, detailed subject-wise marking scheme ...

These hilarious but underrated sitcoms deserve a spot in your rewatch rotation, from Happy Endings to Superstore.

AllRock Bio secures $50 million to advance Roc-101, a promising treatment for pulmonary hypertension, aiming to transform patient care.

AllRock Bio Inc., a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, today announced a $50 million Series A round co-led by Versant ...